Elutia Signs Definitive Agreement To Sell Simpliderm in Transaction Valued At Up To $11 Million, Strengthening Balance Sheet Ahead Of NXT-41X Launch
ELUT•Elutia agrees to sell Simpliderm business
July 16 (Reuters) - Elutia Inc ELUT.O:
- Elutia signs definitive agreement to sell Simpliderm® in transaction valued at up to $11 million, strengthening balance sheet ahead of NXT-41X launch
- Elutia - to receive $8 million cash at closing, up to $3 million in milestone payments
- Elutia - to sell Simpliderm business to Cellution Biologics for up to $11 million
